Moderna, Inc. (NASDAQ:MRNA) Q1 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Moderna First Quarter 2025 Conference Call. At this time, all participants are in a listen-only mode.
Moderna Inc. (MRNA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Leucadia National Ian Cumming And Joseph Steinberg | 245,616 | $6,963,214 | +208% | 0.06% |
| 2. | 25,800 | $731,430 | +15% | 0.01% | |
| 3. | 17,400 | $493,290 | +45% | 0% | |
| 4. | Hurley Capital Charles Goldblum | 167 | $4,734 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $31.53 | 57,493 | Officer, Director | 9,210,686 | 2025-03-03 | Filing | |
| $31.04 | 102,821 | Officer, Director | 9,153,193 | 2025-03-03 | Filing | |
| $31.76 | 31,620 | Director | 312,027 | 2025-03-03 | Filing | |
| $19.00 | 52,631 | Director | 420,407 | 2020-02-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $44.68 | 529 | Officer | 20,446 | 2024-12-09 | Filing | |
| $43.30 | 112 | Officer | 19,837 | 2024-12-03 | Filing | |
| $43.30 | 314 | Officer | 1,443,904 | 2024-12-03 | Filing | |
| $42.79 | 1,420 | Officer | 11,066 | 2024-11-29 | Filing | |
| $42.79 | 1,418 | Officer | 19,717 | 2024-11-29 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 27,181,154 | $770,585,733 | 0.02% | |
| 2. | 24,948,558 | $707,291,620 | 0.62% | |
| 3. | 3,132,974 | $88,819,813 | 0.72% | |
| 4. | 2,048,100 | $58,063,635 | 0.03% | |
| 5. | 1,918,248 | $54,382,335 | 0.01% |
News See All
11 Worst Performing Stocks in S&P 500 So Far in 2025
After a two-year surge of 53%, marking the best performance for the broad market index since the 1997-98 rally, stocks have been taken for a wild ride in 2025 due to uncertainties around recent tariffs...
10 Best Long Term Growth Stocks to Buy According to Billionaires
As per Barclays, the US administration announced numerous executive orders with reforms associated with world trade, immigration, and global geopolitics, resulting in elevated levels of uncertainty and...
Jim Cramer Says Wait A Little & Discusses These 11 Stocks
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on the increasing bearishness in the stock market.
8 Best Gene-Editing Stocks to Buy
Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to treat or prevent diseases.
Jim Cramer Discussed These 9 Stocks Recently
“It's time to praise the winners, the ones that don't need to wait until April 2nd to find out whether their business will be slammed by tariffs when President Trump announces whose earnings will be...
Did Jim Cramer Nail or Miss These 14 Stocks?
During the most recent episode of Mad Money, Jim Cramer described the current stock market as a “short sellers paradise,” offering an ideal moment for those betting against U.S. stocks.
12 Most Promising Biotech Stocks According to Wall Street Analysts
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
10 Stocks To Trade Without Tariffs And Interest Rate Fears
The Federal Reserve this week decided to keep interest rates unchanged, causing Donald Trump to lash out at the Fed chief.
10 Stocks with Potential to Explode in 2025
The recent pullback in US equities can be a sign of an aging bull market and a reaction to developments happening around trade policy, as per Jurrien Timmer, Director of Global Macro for Fidelity Management...
Billionaire Hedge Funds
